Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant

Journal of Infectious Diseases

Volumn 184, Issue 9, 2001, Pages 1211-1215

  Wuorimaa, T ^a   Dagan, R ^b   Vakevainen M ^a   Bailleux, F ^c   Haikala, R ^a   Yaich, M ^c   Eskola, J ^c   Kayhty H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM; DIPHTHERIA TOXOID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; THIOCYANATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFANT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; DIPHTHERIA TOXOID; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TETANUS TOXOID; VACCINATION; VACCINES, CONJUGATE;

EID: 0035500971     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323648     Document Type: Article

References (15)

1. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
2. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides
3. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B
4. Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae
5. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization
6. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination
7. Laboratory correlates of protection against Haemophilus influenzae type b disease: Importance of assessment of antibody avidity and immunologic memory
8. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines
9. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood
10. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults
11. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in healthy toddlers
12. An 11-valent pneumococcal conjugate vaccine: Safety and immunogenicity of primary vaccination in infants
13. Activation of cell mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine
14. Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF
15. Dissecting affinity maturation: A model explaining selection of antibody-forming cells and memory B cells in the germinal centre